Position in BMY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,364,441
-$252,366 QoQ
Shares Held
23,680
-11.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#999
of 2,506 holders
Holding Since
Mar 2020
24 quarters on record
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Global Investments holds $32,800,954 across 11 Drug Manufacturers - General names. BMY ranks #7 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,407 | $12,482,469 | |
| 2 | MRK |
Merck & Co., Inc.
|
52,039 | $6,687,011 | |
| 3 | ABBV |
AbbVie Inc.
|
11,572 | $2,911,978 | |
| 4 | JNJ |
Johnson & Johnson
|
9,808 | $2,490,937 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
11,712 | $1,479,694 | |
| 6 | PFE |
Pfizer Inc
|
60,517 | $1,457,249 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
23,680 | $1,364,441 | |
| 8 | AZN |
Astrazeneca PLC
|
6,543 | $1,240,683 |
All Filings in BMY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,364,441 | 23,680 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,616,807 | 26,658 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,342,944 | 24,897 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $808,778 | 17,933 | Shares | Sole | 2025-11-03 | |
| 2024-12-31 | $660,620 | 11,680 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,415,865 | 27,365 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $2,624,446 | 63,194 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,617,952 | 29,835 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,951,832 | 38,040 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $9,939,350 | 171,250 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $16,713,076 | 261,346 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $16,870,054 | 243,400 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $17,059,632 | 237,104 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $16,981,410 | 238,872 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,014,995 | 259,935 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $19,939,746 | 273,035 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $21,102,606 | 338,454 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,989,650 | 33,626 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,326,338 | 34,815 | Shares | Sole | 2022-01-28 | |
| 2021-03-31 | $2,733,150 | 43,294 | Shares | Sole | 2022-01-27 | |
| 2020-12-31 | $2,716,789 | 43,798 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,501,974 | 41,499 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,705,740 | 46,016 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,111,511 | 19,941 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||